These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20655477)

  • 1. Chemistry and pharmacology of GABAB receptor ligands.
    Froestl W
    Adv Pharmacol; 2010; 58():19-62. PubMed ID: 20655477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment.
    Gjoni T; Urwyler S
    Eur J Pharmacol; 2009 Jan; 603(1-3):37-41. PubMed ID: 19109945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function.
    Urwyler S; Pozza MF; Lingenhoehl K; Mosbacher J; Lampert C; Froestl W; Koller M; Kaupmann K
    J Pharmacol Exp Ther; 2003 Oct; 307(1):322-30. PubMed ID: 12954816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the binding of [3H]CGP54626 to GABAB receptors in the male bullfrog (Rana catesbeiana).
    Asay MJ; Boyd SK
    Brain Res; 2006 Jun; 1094(1):76-85. PubMed ID: 16725130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties.
    Urwyler S; Gjoni T; Koljatić J; Dupuis DS
    Neuropharmacology; 2005 Mar; 48(3):343-53. PubMed ID: 15721166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of action.
    Lehmann A; Antonsson M; Holmberg AA; Blackshaw LA; Brändén L; Bräuner-Osborne H; Christiansen B; Dent J; Elebring T; Jacobson BM; Jensen J; Mattsson JP; Nilsson K; Oja SS; Page AJ; Saransaari P; von Unge S
    J Pharmacol Exp Ther; 2009 Nov; 331(2):504-12. PubMed ID: 19648470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors.
    Alstermark C; Amin K; Dinn SR; Elebring T; Fjellström O; Fitzpatrick K; Geiss WB; Gottfries J; Guzzo PR; Harding JP; Holmén A; Kothare M; Lehmann A; Mattsson JP; Nilsson K; Sundén G; Swanson M; von Unge S; Woo AM; Wyle MJ; Zheng X
    J Med Chem; 2008 Jul; 51(14):4315-20. PubMed ID: 18578471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABAB receptor agonism as a novel therapeutic modality in the treatment of gastroesophageal reflux disease.
    Lehmann A; Jensen JM; Boeckxstaens GE
    Adv Pharmacol; 2010; 58():287-313. PubMed ID: 20655487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GABA(B) antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat.
    Brebner K; Froestl W; Roberts DC
    Psychopharmacology (Berl); 2002 Feb; 160(1):49-55. PubMed ID: 11862373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAB receptor-positive modulators: enhancement of GABAB receptor agonist effects in vivo.
    Koek W; France CP; Cheng K; Rice KC
    J Pharmacol Exp Ther; 2010 Oct; 335(1):163-71. PubMed ID: 20628000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501.
    Urwyler S; Mosbacher J; Lingenhoehl K; Heid J; Hofstetter K; Froestl W; Bettler B; Kaupmann K
    Mol Pharmacol; 2001 Nov; 60(5):963-71. PubMed ID: 11641424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intraperitoneal administration of the GABAB receptor positive allosteric modulator 2,6-di tert-butyl-4-(2-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) on food intake in non-deprived rats.
    Ebenezer IS
    Eur J Pharmacol; 2012 Sep; 690(1-3):115-8. PubMed ID: 22652431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of [(3)H]-CGP54626A binding to heterodimeric GABA(B) receptors stably expressed in mammalian cells.
    Green A; Walls S; Wise A; Green RH; Martin AK; Marshall FH
    Br J Pharmacol; 2000 Dec; 131(8):1766-74. PubMed ID: 11139457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel GABA(B) receptor positive modulators: a patent survey.
    Froestl W
    Expert Opin Ther Pat; 2010 Aug; 20(8):1007-17. PubMed ID: 20645682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of spinal GABA receptors in the regulation of intraspinal acetylcholine release.
    Kommalage M; Höglund AU
    Eur J Pharmacol; 2005 Nov; 525(1-3):69-73. PubMed ID: 16297380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of gamma-aminobutyric acid receptor type B receptors and calcium channels in nociceptive transmission studied in the mouse hemisected spinal cord in vitro: withdrawal symptoms related to baclofen treatment.
    Dang K; Bowery NG; Urban L
    Neurosci Lett; 2004 May; 361(1-3):72-5. PubMed ID: 15135896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783--comparison with the effect of the GABAB receptor direct agonist, baclofen.
    Maccioni P; Fantini N; Froestl W; Carai MA; Gessa GL; Colombo G
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1558-64. PubMed ID: 18616673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An historical perspective on GABAergic drugs.
    Froestl W
    Future Med Chem; 2011 Feb; 3(2):163-75. PubMed ID: 21428811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
    Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
    J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABA(B) receptor.
    Castelli MP; Casu A; Casti P; Lobina C; Carai MA; Colombo G; Solinas M; Giunta D; Mugnaini C; Pasquini S; Tafi A; Brogi S; Gessa GL; Corelli F
    J Pharmacol Exp Ther; 2012 Mar; 340(3):529-38. PubMed ID: 22129594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.